• Company
• Only half of the multiple myeloma drugs reimb in KOR
• by Eo, Yun-Ho Jan 20, 2025 05:54am

• Company
• Ziihera receives orphan drug designation in Korea
• by Eo, Yun-Ho Jan 20, 2025 05:54am

• Company
• [Reporter' View] Results from J.P. Morgan Conference
• by Lee, Seok-Jun Jan 20, 2025 05:53am

• Company
• Expanded reimb for 'Zejula'
• by Son, Hyung Min Jan 17, 2025 05:53am

• Company
• Ultomiris is reimbursed for aHUS in Korea
• by Son, Hyung Min Jan 16, 2025 06:14am

• Company
• Last year's pharma export sales recorded KRW 11T
• by Kim, Jin-Gu Jan 16, 2025 06:14am

• Company
• Elahere receives orphan drug designation in Korea
• by Eo, Yun-Ho Jan 16, 2025 06:13am

• Company
• Companies develop new drugs for Fabry disease
• by Son, Hyung Min Jan 16, 2025 06:13am

• Company
• JW Pharma's hemophilia assay for patients using 'Hemlibra'
• by Kim, Jin-Gu Jan 16, 2025 06:13am

• Company
• China-made new drugs actively enter the global market
• by Son, Hyung Min Jan 16, 2025 06:13am